Search Result - CapitalBiotech Co., Ltd.

All Related Products Other Content

IMAP Platform IMAP can realize application-oriented product development, provides overall solutions to facilitate the transformation of scientific research results.
Solutions for Precise Healthcare Management Modern medicine believes that most diseases are caused by the combined action of internal factors (genes) and external factors (lifestyle, living environment, etc.).
Hybridization Box CapitalBiotech HybSetTM Microarray Hybridization Box holds a 25mm 75mm microarray slide to prevent solution evaporation.
Biochip Design & Fabrication "I" Microfludic Array Platform【IMAP】is a microfluidic chip detection platform independently developed by CapitalBiotech. Focusing on molecular detection products based on SNP/InDel biomarkers, can provide overall solutions including hardware, software, reagents and consumables.
MTB Drug Resistant Detection MDR-TB disease can be quickly diagnosed by using gene chip technology to quickly test for resistance to rifampicin and isoniazid, two of the most important first-line anti-TB drugs.
Drug-Related Deafness Gene Mutations Detection The Drug-Related Deafness Gene Mutations Detection service focuses on detecting drug-induced deafness genes.
Genetic Testing for BRCA1/2 Targeted-Drug Guidance (Germline + Somatic) This test detects somatic and germline mutations in the BRCA1 and BRCA2 genes, and provides information to guide PARP inhibitor therapy in breast & ovarian cancer.
The Disease Susceptibility Genetic Test-Colorectal Cancer This test is based on biochip technology, evaluates the risk of lung cancer from a genetic perspective, and provides guidance on disease prevention.
Single-Cell Sequencing With the development of single-cell technology, the scope of research is no longer limited to the transcriptome, but expanded to the multi-omics level such as the genome, immunome, epigenome, and proteome. In complex biological processes, heterogeneity exists at multiple levels
Single-Cell Immune Repertoire Sequencing Through the 10x Genomics platform, CapitalBiotech can simultaneously detect the transcriptome information and TCR/BCR diversity information of each cell in one experiment.
CapitalBiotech Solution of Detection of Tuberclosis
Lab-on-a-chip Introduction
Knowledge About Transcriptome Sequencing In a broad sense, the transcriptome refers to the collection of all transcripts in a cell under a certain physiological condition, including messenger RNA, ribosomal RNA, transfer RNA and non-coding R...
Recent Advances in the Microfluidic Platform for Programming Cell-Based Biomaterials Microfluidic Platforms Promote the Development of Cell-Based Living MaterialsCell-based living materials, including single cells, cell-loaded fibers, cell sheets, organoids, and organs, have been cons...
Applications and Innovations of Microfluidic Platforms in Drug Analysis The prospects of microfluidic platforms in drug analysis applicationsThe pharmaceutical development field is now facing increasingly powerful research and development barriers and steep patent cliffs,...